Dopamine Receptor Partial Agonists: Do They Differ in Their Clinical Efficacy?

Dopamine receptor partial agonists (DRPAs; aripiprazole, brexpiprazole, and cariprazine) constitute a novel class of antipsychotics. Although they share a similar mechanism of action, DRPAs differ in their pharmacodynamics, pharmacokinetics, drug interactions, or safety and tolerability. The antipsy...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohr, Pavel, Masopust, Jirí, Kopeček, Miloslav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821167/
https://www.ncbi.nlm.nih.gov/pubmed/35145438
http://dx.doi.org/10.3389/fpsyt.2021.781946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821167/
https://www.ncbi.nlm.nih.gov/pubmed/35145438
http://dx.doi.org/10.3389/fpsyt.2021.781946

Ejemplares similares